| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers U > Headlines for US Oncology, Inc. > News item |
US Oncology looking to cut pricing on term loan
New York, Oct. 25 - US Oncology, Inc. said it will be seeking to amend its term loan to cut the interest rate.
The amendment will be led by J.P. Morgan Securities Inc. and Wachovia Capital Markets, LLC.
US Oncology, a Houston-based provider of healthcare services for cancer treatment and research, currently has $381 million outstanding on the loan.
The company also announced that it expects revenues of $640 million to $650 million for the quarter ended Sept. 30, 2005, with EBITDA of $57 million to $60 million and net income of $9.5 million to $11 million.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.